Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenqing Wang

Showing results (341-350 of 399) with videos related to

Pageof 40
Sort By:
BMC Cancer|February 24, 2020
Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinomaWenjie Ni, Jinsong Yang, Wei Deng, et al.
Nature Microbiology|December 15, 2025
Zoonotic Streptococcus imports glucose to inhibit stringent response and promote growth during meningitisChen Yuan, Karthik Hullahalli, Hao Huang, et al.
BMC Cancer|April 2, 2025
Multi-modal radiomics features to predict overall survival of locally advanced esophageal cancer after definitive chemoradiotherapyNuo Yu, Yidong Wan, Lijing Zuo, et al.
International Journal of Cancer|October 15, 2025
Simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal squamous cell carcinoma: A multicenter, open-label, randomized, phase III clinical trialWeiming Han, Linrui Gao, Xiaomin Wang, et al.
Cancers|January 11, 2025
Multi-Centered Pre-Treatment CT-Based Radiomics Features to Predict Locoregional Recurrence of Locally Advanced Esophageal Cancer After Definitive ChemoradiotherapyNuo Yu, Xiaolin Ge, Lijing Zuo, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|July 11, 2024
Effectiveness and safety of combined nimotuzumab and S-1 chemotherapy with concurrent radiotherapy for locally advanced esophageal cancer in malnourished and elderly patients: A prospective phase II studyGuojie Feng, Jiao Li, Nuo Yu, et al.
The Annals of Thoracic Surgery|August 11, 2019
Systemic Inflammation-Immune Status Predicts Survival in Stage III-N2 Non-Small Cell Lung CancerJianyang Wang, Zhouguang Hui, Yu Men, et al.
Veterinary Microbiology|February 11, 2025
The clinical characteristics of Streptococcus equi ssp. zooepidemicus causing acute death in pigs and its prevention with chimeric monoclonal antibodiesChen Yuan, Yuchang Wang, Xiaowen Zhang, et al.
Frontiers in Immunology|December 11, 2023
Efficacy and safety of definitive chemoradiotherapy with or without induction immune checkpoint inhibitors in patients with stage III non-small cell lung cancerYin Yang, Jianyang Wang, Tao Zhang, et al.
Frontiers in Oncology|July 8, 2021
Definitive Simultaneous Integrated Boost Versus Conventional-Fractionated Intensity Modulated Radiotherapy for Patients With Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched AnalysisChen Li, Lijun Tan, Xiao Liu, et al.
Pageof 40

Showing results (341-350 of 399) with videos related to

Sort By:
Pageof 40
BMC Cancer|February 24, 2020
Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinomaWenjie Ni, Jinsong Yang, Wei Deng, et al.
Nature Microbiology|December 15, 2025
Zoonotic Streptococcus imports glucose to inhibit stringent response and promote growth during meningitisChen Yuan, Karthik Hullahalli, Hao Huang, et al.
BMC Cancer|April 2, 2025
Multi-modal radiomics features to predict overall survival of locally advanced esophageal cancer after definitive chemoradiotherapyNuo Yu, Yidong Wan, Lijing Zuo, et al.
International Journal of Cancer|October 15, 2025
Simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal squamous cell carcinoma: A multicenter, open-label, randomized, phase III clinical trialWeiming Han, Linrui Gao, Xiaomin Wang, et al.
Cancers|January 11, 2025
Multi-Centered Pre-Treatment CT-Based Radiomics Features to Predict Locoregional Recurrence of Locally Advanced Esophageal Cancer After Definitive ChemoradiotherapyNuo Yu, Xiaolin Ge, Lijing Zuo, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|July 11, 2024
Effectiveness and safety of combined nimotuzumab and S-1 chemotherapy with concurrent radiotherapy for locally advanced esophageal cancer in malnourished and elderly patients: A prospective phase II studyGuojie Feng, Jiao Li, Nuo Yu, et al.
The Annals of Thoracic Surgery|August 11, 2019
Systemic Inflammation-Immune Status Predicts Survival in Stage III-N2 Non-Small Cell Lung CancerJianyang Wang, Zhouguang Hui, Yu Men, et al.
Veterinary Microbiology|February 11, 2025
The clinical characteristics of Streptococcus equi ssp. zooepidemicus causing acute death in pigs and its prevention with chimeric monoclonal antibodiesChen Yuan, Yuchang Wang, Xiaowen Zhang, et al.
Frontiers in Immunology|December 11, 2023
Efficacy and safety of definitive chemoradiotherapy with or without induction immune checkpoint inhibitors in patients with stage III non-small cell lung cancerYin Yang, Jianyang Wang, Tao Zhang, et al.
Frontiers in Oncology|July 8, 2021
Definitive Simultaneous Integrated Boost Versus Conventional-Fractionated Intensity Modulated Radiotherapy for Patients With Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched AnalysisChen Li, Lijun Tan, Xiao Liu, et al.
Pageof 40